Contineum Therapeutics, Inc. - CL A (CTNM)

Q2 2024 13F Holders as of 6/30/2024

Type / Class
Equity / CL A
Number of holders
49
Total Shares
13M
Shares change
+13M
Total reported value, excl. options
$229M
Value change
+$229M
Put/Call ratio
0
Number of buys
47
Number of sells
0
Price
$17.61
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.